Proteome Sciences plc
PRM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £24 | £23 |
| % Growth | -2.8% | -100% | 5.1% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 13.7% | 32.8% | 0% | 0% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | -£0 | -£0 | £0 | -£0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | -£0 | -£0 | £0 | £0 |
| % Margin | -48.1% | -32.2% | 0% | 0% |
| Other Income/Exp. Net | -£0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | -£0 | -£0 | £0 | £0 |
| Tax Expense | £0 | £0 | -£0 | £0 |
| Net Income | -£0 | -£0 | £0 | £0 |
| % Margin | -69.7% | -48.6% | 0% | 0% |
| EPS | -0.012 | -0.008 | 0.005 | 0 |
| % Growth | -38.6% | -284.4% | 2,150% | – |
| EPS Diluted | -0.012 | -0.008 | 0.004 | 0 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£0 | -£0 | £0 | £0 |
| % Margin | -31% | -22.6% | 0% | 0% |